Diagnostic Imaging Devices - Papua New Guinea

The Diagnostic Imaging Devices market market in Papua New Guinea is anticipated to witness a substantial growth in revenue, with projections indicating that it will reach US$5.29m by 2024.
This growth is expected to continue, with an estimated annual growth rate of 3.03% from 2024 to 2029.
As a result, the market volume is forecasted to reach US$6.14m by 2029.
In global comparison, it is noteworthy that the United States is projected to generate the highest revenue in the Diagnostic Imaging Devices market market, with an impressive figure of US$11.93bn in 2024.
Papua New Guinea is experiencing a growing demand for diagnostic imaging devices to improve healthcare access and outcomes in remote areas.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Papua New Guinea is experiencing significant growth and development due to various factors. Customer preferences in the Diagnostic Imaging Devices market in Papua New Guinea are influenced by several factors. One of the key factors is the increasing demand for advanced medical technologies and diagnostic equipment. As the healthcare sector in Papua New Guinea continues to develop and expand, there is a growing need for accurate and efficient diagnostic imaging devices. Patients and healthcare providers are increasingly demanding state-of-the-art equipment that can provide accurate and detailed images for diagnosis and treatment planning. Additionally, there is a preference for portable and compact devices that can be easily transported to remote areas with limited access to healthcare facilities. Trends in the market indicate a shift towards digital imaging technologies. Digital imaging devices offer several advantages over traditional film-based systems, including faster image acquisition, improved image quality, and the ability to easily store and share images electronically. This trend is driven by advancements in technology and the increasing availability of high-speed internet connections in Papua New Guinea. Healthcare providers are adopting digital imaging devices to improve workflow efficiency and enhance patient care. Local special circumstances in Papua New Guinea also contribute to the development of the Diagnostic Imaging Devices market. The country has a growing population and an increasing burden of non-communicable diseases, such as cardiovascular diseases and cancer. This has led to a greater demand for diagnostic imaging devices to aid in the early detection and treatment of these diseases. Additionally, the geographical landscape of Papua New Guinea, with its remote and isolated regions, poses challenges for healthcare delivery. Portable and mobile diagnostic imaging devices are particularly valuable in these areas, allowing healthcare providers to reach patients in remote locations and provide timely and accurate diagnoses. Underlying macroeconomic factors also play a role in the development of the Diagnostic Imaging Devices market in Papua New Guinea. The country has been experiencing steady economic growth in recent years, which has led to increased healthcare spending. The government is investing in upgrading healthcare infrastructure and improving access to quality healthcare services, including diagnostic imaging. Furthermore, the growing middle class in Papua New Guinea has higher disposable incomes and is willing to spend on advanced healthcare services, including diagnostic imaging. In conclusion, the Diagnostic Imaging Devices market in Papua New Guinea is developing due to customer preferences for advanced medical technologies, the trend towards digital imaging, local special circumstances such as the burden of non-communicable diseases and the geographical landscape, and underlying macroeconomic factors such as economic growth and increased healthcare spending.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.